Rafael Rosell

24.8k citations
144 papers · 8.0k · 1 hit paper · h-index 43

Impact in

Papers in

Rafael Rosell

141 papers receiving 7.8k citations

Rafael Rosell's Hit Papers

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. 2002 · 551 citations
5510+8+16Years since publication100200300400500

Peers

Rafael Rosell
Comparison fields: 5 of 125
  • Oncology 4.3k
  • Pulmonary and Respiratory Medicine 4.8k
  • Cancer Research 1.7k
  • Molecular Biology 3.2k
  • Pathology and Forensic Medicine 630
Replace Sanja Đačić with:
Sanja Đačić United States
Rogério Lilenbaum United States
Rafał Dziadziuszko Poland
Lucian R. Chirieac United States
Viktor Grünwald Germany
Martin Filipits Austria
Robert T. Heelan United States
Denis Moro‐Sibilot France
Jamie E. Chaft United States
Hidefumi Sasaki Japan
Rafael Rosell relative to Sanja Đačić United States Sanja Đačić's profile →
Citations per field
00.5×1.5×
Sanja Đačić · 1×
Citations per year

Countries citing papers authored by Rafael Rosell

Since Specialization
Citations

This map shows the geographic impact of Rafael Rosell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Rosell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Rosell more than expected).

Fields of papers citing papers by Rafael Rosell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Rosell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Rosell. The network helps show where Rafael Rosell may publish in the future.

Co-authors

The 25 scholars most cited alongside Rafael Rosell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rafael Rosell Line = papers co-authored together Rafael Rosell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.
Hit paper breakdown →
2002551
2 1999440
3 2007344
4 1997300
5 2004296
6 1999290
7 2005280
8 2010274
9 2004256
10 2004255
11 2007255
12 2015248
13 2010247
14 2014180
15 2007167
16 2003148
17 2006145
18 2006125
19 2005115
20 2005114

About Rafael Rosell

Rafael Rosell is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 144 papers that have together received 8.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (104 papers), Lung Cancer Research Studies (53 papers), Cancer Genomics and Diagnostics (33 papers), Lung Cancer Diagnosis and Treatment (25 papers), Colorectal Cancer Treatments and Studies (24 papers), Cancer therapeutics and mechanisms (20 papers), DNA Repair Mechanisms (16 papers) and Genetic factors in colorectal cancer (10 papers). The work is most often cited by research in Oncology (4.3k citations), Pulmonary and Respiratory Medicine (4.8k citations), Cancer Research (1.7k citations), Molecular Biology (3.2k citations) and Pathology and Forensic Medicine (630 citations). Rafael Rosell has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include José Javier Sánchez, Miquel Tarón, Carlos Camps, Enriqueta Felip, Dolores Isla, Bartomeu Massutí, José Miguel Sánchez, Cristina Queralt, Vicente Alberola and J Maestre. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Annals of Oncology, Clinical Lung Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact